FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4318924396> ?p ?o ?g. }

• W4318924396 endingPage "118" @default.
• W4318924396 startingPage "113" @default.
• W4318924396 abstract "After the emergence of SARS-CoV-2 in late 2019, transmission expanded globally, and on January 30, 2020, COVID-19 was declared a public health emergency of international concern.* Analysis of the early Wuhan, China outbreak (1), subsequently confirmed by multiple other studies (2,3), found that 80% of deaths occurred among persons aged ≥60 years. In anticipation of the time needed for the global vaccine supply to meet all needs, the World Health Organization (WHO) published the Strategic Advisory Group of Experts on Immunization (SAGE) Values Framework and a roadmap for prioritizing use of COVID-19 vaccines in late 2020 (4,5), followed by a strategy brief to outline urgent actions in October 2021.† WHO described the general principles, objectives, and priorities needed to support country planning of vaccine rollout to minimize severe disease and death. A July 2022 update to the strategy brief§ prioritized vaccination of populations at increased risk, including older adults,¶ with the goal of 100% coverage with a complete COVID-19 vaccination series** for at-risk populations. Using available public data on COVID-19 mortality (reported deaths and model estimates) for 2020 and 2021 and the most recent reported COVID-19 vaccination coverage data from WHO, investigators performed descriptive analyses to examine age-specific mortality and global vaccination rollout among older adults (as defined by each country), stratified by country World Bank income status. Data quality and COVID-19 death reporting frequency varied by data source; however, persons aged ≥60 years accounted for >80% of the overall COVID-19 mortality across all income groups, with upper- and lower-middle-income countries accounting for 80% of the overall estimated excess mortality. Effective COVID-19 vaccines were authorized for use in December 2020, with global supply scaled up sufficiently to meet country needs by late 2021 (6). COVID-19 vaccines are safe and highly effective in reducing severe COVID-19, hospitalizations, and mortality (7,8); nevertheless, country-reported median completed primary series coverage among adults aged ≥60 years only reached 76% by the end of 2022, substantially below the WHO goal, especially in middle- and low-income countries. Increased efforts are needed to increase primary series and booster dose coverage among all older adults as recommended by WHO and national health authorities." @default.
• W4318924396 created "2023-02-03" @default.
• W4318924396 creator A5000171889 @default.
• W4318924396 creator A5002574186 @default.
• W4318924396 creator A5003670051 @default.
• W4318924396 creator A5008769512 @default.
• W4318924396 creator A5019072489 @default.
• W4318924396 creator A5022592491 @default.
• W4318924396 creator A5022842863 @default.
• W4318924396 creator A5023324131 @default.
• W4318924396 creator A5025136686 @default.
• W4318924396 creator A5025657799 @default.
• W4318924396 creator A5026339768 @default.
• W4318924396 creator A5028501984 @default.
• W4318924396 creator A5029572056 @default.
• W4318924396 creator A5030429912 @default.
• W4318924396 creator A5031422274 @default.
• W4318924396 creator A5031488414 @default.
• W4318924396 creator A5036267860 @default.
• W4318924396 creator A5040669969 @default.
• W4318924396 creator A5041054443 @default.
• W4318924396 creator A5042367148 @default.
• W4318924396 creator A5042919411 @default.
• W4318924396 creator A5044596360 @default.
• W4318924396 creator A5045284250 @default.
• W4318924396 creator A5047854140 @default.
• W4318924396 creator A5048329237 @default.
• W4318924396 creator A5050261367 @default.
• W4318924396 creator A5051023362 @default.
• W4318924396 creator A5052824078 @default.
• W4318924396 creator A5054400310 @default.
• W4318924396 creator A5055303961 @default.
• W4318924396 creator A5055802709 @default.
• W4318924396 creator A5057251622 @default.
• W4318924396 creator A5062228670 @default.
• W4318924396 creator A5066713225 @default.
• W4318924396 creator A5068851939 @default.
• W4318924396 creator A5068993690 @default.
• W4318924396 creator A5072132649 @default.
• W4318924396 creator A5072816807 @default.
• W4318924396 creator A5074205906 @default.
• W4318924396 creator A5075565282 @default.
• W4318924396 creator A5076154404 @default.
• W4318924396 creator A5076413043 @default.
• W4318924396 creator A5076578933 @default.
• W4318924396 creator A5079152145 @default.
• W4318924396 creator A5086064039 @default.
• W4318924396 creator A5086163583 @default.
• W4318924396 creator A5088414315 @default.
• W4318924396 date "2023-02-03" @default.
• W4318924396 modified "2023-09-30" @default.
• W4318924396 title "COVID-19 Mortality and Progress Toward Vaccinating Older Adults — World Health Organization, Worldwide, 2020–2022" @default.
• W4318924396 cites W3035011439 @default.
• W4318924396 cites W3138018429 @default.
• W4318924396 cites W4210277429 @default.
• W4318924396 cites W4229028010 @default.
• W4318924396 cites W4285719527 @default.
• W4318924396 cites W4315779712 @default.
• W4318924396 doi "https://doi.org/10.15585/mmwr.mm7205a1" @default.
• W4318924396 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36730046" @default.
• W4318924396 hasPublicationYear "2023" @default.
• W4318924396 type Work @default.
• W4318924396 citedByCount "18" @default.
• W4318924396 countsByYear W43189243962023 @default.
• W4318924396 crossrefType "journal-article" @default.
• W4318924396 hasAuthorship W4318924396A5000171889 @default.
• W4318924396 hasAuthorship W4318924396A5002574186 @default.
• W4318924396 hasAuthorship W4318924396A5003670051 @default.
• W4318924396 hasAuthorship W4318924396A5008769512 @default.
• W4318924396 hasAuthorship W4318924396A5019072489 @default.
• W4318924396 hasAuthorship W4318924396A5022592491 @default.
• W4318924396 hasAuthorship W4318924396A5022842863 @default.
• W4318924396 hasAuthorship W4318924396A5023324131 @default.
• W4318924396 hasAuthorship W4318924396A5025136686 @default.
• W4318924396 hasAuthorship W4318924396A5025657799 @default.
• W4318924396 hasAuthorship W4318924396A5026339768 @default.
• W4318924396 hasAuthorship W4318924396A5028501984 @default.
• W4318924396 hasAuthorship W4318924396A5029572056 @default.
• W4318924396 hasAuthorship W4318924396A5030429912 @default.
• W4318924396 hasAuthorship W4318924396A5031422274 @default.
• W4318924396 hasAuthorship W4318924396A5031488414 @default.
• W4318924396 hasAuthorship W4318924396A5036267860 @default.
• W4318924396 hasAuthorship W4318924396A5040669969 @default.
• W4318924396 hasAuthorship W4318924396A5041054443 @default.
• W4318924396 hasAuthorship W4318924396A5042367148 @default.
• W4318924396 hasAuthorship W4318924396A5042919411 @default.
• W4318924396 hasAuthorship W4318924396A5044596360 @default.
• W4318924396 hasAuthorship W4318924396A5045284250 @default.
• W4318924396 hasAuthorship W4318924396A5047854140 @default.
• W4318924396 hasAuthorship W4318924396A5048329237 @default.
• W4318924396 hasAuthorship W4318924396A5050261367 @default.
• W4318924396 hasAuthorship W4318924396A5051023362 @default.
• W4318924396 hasAuthorship W4318924396A5052824078 @default.
• W4318924396 hasAuthorship W4318924396A5054400310 @default.
• W4318924396 hasAuthorship W4318924396A5055303961 @default.
• W4318924396 hasAuthorship W4318924396A5055802709 @default.
• W4318924396 hasAuthorship W4318924396A5057251622 @default.
• W4318924396 hasAuthorship W4318924396A5062228670 @default.

• next